AN2 Therapeutics Inc (ANTX) Financials

$5.98

$0.09 (1.53%)

As on 08-Sep-2026 16:00EDT

Market cap

$222 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

2.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	0.08	--
Gross Profit	--	--	--	--	-0.08	--
Operating Expenses	38.81	38.11	54.55	69.64	42.26	21.57
Operating Profit (EBIT)	-38.81	-38.11	-54.55	-69.64	-42.26	-21.57
Other Income	--	--	--	--	--	--
Profit before Tax	-36.28	-35.17	-51.32	-64.73	-40.96	-21.54
Provision for Tax	--	--	--	-0.07	0.51	-0.07
Profit after Tax (Net Income)	-36.28	-35.17	-51.32	-64.73	-41.47	-21.47
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-42.78	-28.06

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	75.92	53.06	81.85	124.70	95.37	61.91
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.17	0.17	--	--	0.00	0.01
Current Liabilities	5.59	8.72	10.24	14.04	7.19	3.40
Total Liabilities	87.26	61.95	92.09	138.74	102.56	65.32

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	1.69	2.01	5.83	28.24	3.94	5.21
Current Assets	79.99	59.94	86.26	110.51	98.62	60.11
Total Assets	87.26	61.95	92.09	138.74	102.56	65.32
Total Debt*	--	--	--	--	0.05	--
Net Current Assets	74.41	51.22	76.02	96.46	91.44	56.71

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-29.83	-49.26	-53.29	-33.46	-20.48
Cash Flow from Investing Activities	--	28.31	54.59	-43.28	-21.77	-50.02
Cash from Financing Activities	--	0.11	0.37	84.99	70.36	78.54
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.07	-1.16	-1.72	-2.18	-2.14	-1.18
Cash EPS ($)	--	-1.16	-1.72	-2.18	-2.14	-1.18
Adjusted Book Value ($)	--	1.76	2.74	4.19	4.92	3.41
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.99	-1.65	-1.79	-1.72	-1.13
Free Cash Flow per Share ($)	--	-0.99	-1.65	-1.79	-1.72	-1.13

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-52.14	-49.69	-58.81	-52.72	-66.42
ROE (%)	-56.25	-52.14	-49.69	-58.83	-52.73	-66.42
ROA (%)	-42.66	-45.67	-44.47	-53.65	-49.41	-61.75
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	--	--	20.72	-53.17	-95.89	-196.18
Net Profit Growth (%)	2.95	31.46	20.72	-56.09	-93.12	-57.90
EPS Growth (%)	13.86	0.32	0.21	-0.02	-0.81	--
Book Value Growth (%)	-25.66	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.98	-0.80	-9.41	-4.46	--
Price / Book Value	2.72	0.65	0.50	4.89	1.94	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-2.11	0.67	-13.11	102.38	-2.05	--
Close Price ($)	4.84	1.14	1.38	20.49	9.53	--
High Price ($)	6.91	1.55	22.15	21.70	23.58	--
Low Price ($)	1.00	1.01	0.87	4.87	6.88	--
Market Cap ($ Cr)	222.27	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	--	--	--	0.00	--
Short term debt to equity ratio	--	--	--	--	0.00	--
Current Ratio	14.32	6.87	8.43	7.87	13.72	17.70
Quick Ratio	14.32	--	--	--	--	--
Interest Coverage	--	--	--	--	-82.22	-312.67

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	7,554.03	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.